AI Snips
Chapters
Transcript
Episode notes
Psychedelic Therapy Is Promising But Not Proven
- Psychedelic-assisted psychotherapy shows early promise but existing results are preliminary and vulnerable to bias.
- James Rucker notes most positive phase 1–2 trials may reflect investigator and participant expectancy; definitive phase 3 trials are needed over years.
Only Use Psychedelics Within Licensed Trials
- Psychedelics and MDMA are only legal in clinical trials and require special licences for therapeutic use.
- James Rucker warns these are Schedule I drugs in the US/UK, so any therapeutic use outside trials carries heavy legal risk.
Wim Hof Triggers Acute Effects Not Proven Long Term
- Wim Hof breathing plus cold exposure produces strong acute physiological changes but long-term benefits and dosing are unclear.
- Sarah Davie highlights one small lab study showing transient immune marker changes that returned to baseline within hours.